|
    PFE U.S.: NYSE

    Pfizer Inc.

    PFEUS
    After Hours
    Last Updated: May 26, 2023 7:59 p.m. EDT Delayed quote

    $ 37.65

    0.05 0.13%
    After Hours Volume: 1.73M
    Close Chg Chg %
    $37.60 -0.23 -0.61%
    Advanced Charting
    Volume: 20.23M 65 Day Avg: 24.21M
    84% vs Avg
    37.56 Day Range 38.44
    36.17 52 Week Range 54.93

    Partner Center

    Your Watchlists

    Customize MarketWatch

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    No Saved Watchlists

    Create a list of the investments you want to track.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    PFE Overview

    Key Data

    • Open $38.04
    • Day Range 37.56 - 38.44
    • 52 Week Range 36.17 - 54.93
    • Market Cap $212.26B
    • Shares Outstanding 5.65B
    • Public Float 5.64B
    • Beta 0.59
    • Rev. per Employee $1.120M
    • P/E Ratio 7.41
    • EPS $5.07
    • Yield 4.36%
    • Dividend $0.41
    • Ex-Dividend Date May 11, 2023
    • Short Interest 45.92M 05/15/23
    • % of Float Shorted 0.81%
    • Average Volume 24.21M

    Performance

    5 Day
    • 2.26%
    1 Month
    • -3.32%
    3 Month
    • -9.94%
    YTD
    • -26.62%
    1 Year
    • -30.25%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 25 Full Ratings

    Recent News

    Read full story

    Pfizer Inc. stock falls Friday, underperforms market

    Read full story

    Drugmakers Released a Ton of New Cancer Treatment Data. The Biggest Developments.

    Read full story

    Greece’s Economy Is on the Mend. What the U.S. Can Learn From Its Revival.

    Read full story

    Pfizer Inc. stock underperforms Thursday when compared to competitors

    Pfizer wins full FDA approval for oral COVID therapy Paxlovid for adults at high risk of developing severe illness

    Pfizer’s Paxlovid COVID treatment granted full FDA approval for adult patients at high risk of developing severe illness

    Read full story

    Lockheed Martin is latest U.S. issuer to tap corporate-bond market ahead of potential debt-ceiling turmoil

    Read full story

    Pfizer Inc. stock underperforms Wednesday when compared to competitors

    Read full story

    Pfizer Inc. stock rises Tuesday, outperforms market

    Read full story

    New Weight-Loss Pills Are Coming. What to Know.

    Seagate joins flurry of bond issuance with plans to issue up to $1 billion of high-yield bonds

    Health Care Up Slightly as Pfizer Rallies on Weight-Drug Hopes -- Health Care Roundup

    Read full story

    Micron, Meta and Nike stocks fall and Nio, DraftKings shares rally, and other stocks on the move

    Pfizer shares jump 4% after diabetes drug shows weight-loss results

    Read full story

    FDA advisers vote in favor of Pfizer’s maternal RSV vaccine

    Read full story

    Charles Schwab raises $2.5 billion in bond offering amid surge in corporate-bond deals

    Read full story

    Western Alliance Bancorp deposit growth and debt ceiling optimism sparks rally in bank stocks

    Read full story

    Comerica leads S&P 500 gainers in regional-bank rally, Target gains and other stocks on the move

    Read full story

    Pfizer, Amgen, and 7 More Cheap Healthcare Stocks for Investors to Consider

    Read full story

    Pfizer issues fourth-biggest U.S. corporate bond deal on record as borrowing pace picks up ahead of debt-ceiling deadline

    The 3 Best Healthcare Stocks to Buy for June 2023

    on InvestorPlace.com

    5 Value Stocks In The Healthcare Sector

    on Benzinga.com

    EMA Panel Endorses Novavax's (NVAX) COVID Jab for Full Approval

    on Zacks.com

    The Top Healthcare Stocks to Buy With $100

    on Motley Fool

    Investing $43 in This Stock per Week for 5 Years Could Give You $500 in Annual Dividend Income

    on Motley Fool

    3 No-Brainer Stocks to Buy for Under $100 Right Now

    on Motley Fool

    Novo Nordisk (NVO) Growth Hormone Drug Gets Positive CHMP Opinion

    on Zacks.com

    Pfizer's (PFE) COVID-19 Oral Treatment Gets FDA Nod in Adults

    on Zacks.com

    Amazon's Prime Video Trolls Netflix's Password Crackdown, Tesla Data Leak Exposes Safety Nightmare, Elon Musk's Brain Chip Company Gets FDA Nod For Human Trial: Top Stories For Today

    on Benzinga.com

    Amended European Deal For BioNTech-Pfizer's Covid-19 Vaccines Allows Reduced Purchases

    on Benzinga.com

    After Back To Back Failure For Keytruda Plus Lenvima, Merck Touts Durable Clinical Benefit For The Combo In Advanced Kidney Cancer

    on Benzinga.com

    Analysts Are Neutral on These Healthcare Stocks: Illumina (ILMN), Pfizer (PFE)

    on TipRanks.com

    Why Pfizer Stock Slipped by 2% Today

    on Motley Fool

    Value Stocks Hit 15-Month Low Against Growth As AI Fuels Tech's Vengeance Over 2022's Rate-Hike-Induced Market Fall

    on Benzinga.com

    BioNTech's Ready-to-Use Single Dose Vaccine, the Perfect Counterattack to China's Rising XBB1.5 Cases

    on Benzinga.com

    Wall Street Expects These Stocks to Soar 175% and 545%. Should You Buy?

    on Motley Fool

    FDA Nods to Pfizer's Paxlovid for COVID-19: A Potential $8 Billion Lifesaver in 2023

    on Benzinga.com

    Can Pfizer Stock Double Your Money in 3 Years?

    on Motley Fool

    7 Top Stock Tips for June 2023

    on InvestorPlace.com

    Allison Transmission and Alico have been highlighted as Zacks Bull and Bear of the Day

    on Zacks.com

    Pfizer Inc.

    Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

    Competitors

    Name Chg % Market Cap
    Johnson & Johnson -0.04% $401.11B
    Eli Lilly & Co. -0.36% $404.19B
    Abbott Laboratories 0.71% $178.89B
    Merck & Co. Inc. -1.10% $281.83B
    Novartis AG 0.41% CHF176.07B
    AstraZeneca PLC ADR 1.20% $225.23B
    AstraZeneca PLC 1.22% £182.64B
    Bristol Myers Squibb Co. -1.15% $134.08B
    Amgen Inc. -0.24% $115.91B
    Moderna Inc. -0.18% $48.12B